• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

if true what a joke GILD will reverse the case

anonymous

Guest
. . .The evidence does not pertain to Gilead’s waiver theory and does not pertain to the only unclean hands theory that Gilead disclosed during discovery. In its interrogatory response regarding its unclean hand theory, Gilead identified a single basis for its unclean hands defense: that Merck had "obtain[ed] its patent rights by deriving the invention from Pharmasset’s confidential disclosures which renders it inequitable for Merck to now assert the patents against Gilead. . . ."

We will see what comes out after the appeal is settled.
 

<



. . .The evidence does not pertain to Gilead’s waiver theory and does not pertain to the only unclean hands theory that Gilead disclosed during discovery. In its interrogatory response regarding its unclean hand theory, Gilead identified a single basis for its unclean hands defense: that Merck had "obtain[ed] its patent rights by deriving the invention from Pharmasset’s confidential disclosures which renders it inequitable for Merck to now assert the patents against Gilead. . . ."

We will see what comes out after the appeal is settled.
Our lawyers will eat them alive!